Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Reinhardt

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Cancer Research|August 14, 2019
Dual Inhibition of GLUT1 and the ATR/CHK1 Kinase Axis Displays Synergistic Cytotoxicity in <i>KRAS</i>-Mutant Cancer CellsJohanna Erber, Joachim D Steiner, Jörg Isensee, et al.
Haematologica|July 13, 2023
Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survivalSara Oubari, Ute Hegenbart, Renate Schoder, et al.
Blood|June 27, 2022
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphomaGrace M Pindzola, Raud Razzaghi, Rachel N Tavory, et al.
Theranostics|September 20, 2019
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53Maximiliane Schuldner, Bastian Dörsam, Olga Shatnyeva, et al.
Leukemia|November 8, 2014
Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemiaM F Huelsemann, M Patz, L Beckmann, et al.
Leukemia|June 11, 2021
Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPPRon D Jachimowicz, Wolfram Klapper, Gunther Glehr, et al.
Leukemia|October 25, 2016
Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemiaG Lohmann, E Vasyutina, J Bloehdorn, et al.
Bone Marrow Transplantation|June 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL)Anna Ossami Saidy, Ariane Boumendil, Peter Dreger, et al.
Cell Death & Disease|May 22, 2015
Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53A Desantis, T Bruno, V Catena, et al.
Cell Death & Disease|May 20, 2024
CDK9 inhibition as an effective therapy for small cell lung cancerL Valdez Capuccino, T Kleitke, B Szokol, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Cancer Research|August 14, 2019
Dual Inhibition of GLUT1 and the ATR/CHK1 Kinase Axis Displays Synergistic Cytotoxicity in <i>KRAS</i>-Mutant Cancer CellsJohanna Erber, Joachim D Steiner, Jörg Isensee, et al.
Haematologica|July 13, 2023
Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survivalSara Oubari, Ute Hegenbart, Renate Schoder, et al.
Blood|June 27, 2022
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphomaGrace M Pindzola, Raud Razzaghi, Rachel N Tavory, et al.
Theranostics|September 20, 2019
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53Maximiliane Schuldner, Bastian Dörsam, Olga Shatnyeva, et al.
Leukemia|November 8, 2014
Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemiaM F Huelsemann, M Patz, L Beckmann, et al.
Leukemia|June 11, 2021
Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPPRon D Jachimowicz, Wolfram Klapper, Gunther Glehr, et al.
Leukemia|October 25, 2016
Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemiaG Lohmann, E Vasyutina, J Bloehdorn, et al.
Bone Marrow Transplantation|June 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL)Anna Ossami Saidy, Ariane Boumendil, Peter Dreger, et al.
Cell Death & Disease|May 22, 2015
Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53A Desantis, T Bruno, V Catena, et al.
Cell Death & Disease|May 20, 2024
CDK9 inhibition as an effective therapy for small cell lung cancerL Valdez Capuccino, T Kleitke, B Szokol, et al.
Pageof 12